Skip to main content

Table 1 Similarities and differences between SARS-CoV-2 and MPX

From: SARS-CoV-2 and monkeypox: what is common and what is not in a present pandemic versus a potential one—a neuropsychiatric narrative review

 

SARS-CoV-2

MPX

Virological classification

Orthocoronavirinae subfamily, Coronaviridae family

Chordopoxvirinae subfamily, Poxviridae family

Nucleic acid structure

Single stranded RNA

Double stranded DNA

Forms

Alpha, Beta, Gamma, Delta, Omicron with its different clades

Nigerian clade and democratic republic of Congo clade

Abundant form worldwide

Omicron

Nigerian clade

Way of transmission

Droplet, direct contact, aerosol

Long-term close direct contact with infected animals, contact with infected body fluids, human-to-human transmission among homosexual men

Nature of spread

Tides and waves

Constant rise

Source of body entrance

Attaching its surface spikes to ACE2 receptors on endothelial cells

Macropinocytosis

Commonest neuropsychiatric manifestations

Strokes, encephalitis, peripheral neuropathy, autoimmune neuropathy, fatigue, lack of concentration, inattention, memory lapses, generalized weakness, sleep disturbance, depression, anxiety, post-traumatic stress, chronic headache

Headache, myalgia, photophobia, pain and fatigue, seizures, encephalitis, anxiety, depression up to suicide

Manifestations in pediatrics

Less aggressive yet rarely MIS-C can develop

More aggressive

  1. SARS-CoV-2: severe acute respiratory syndrome corona virus 2, MPX: monkeypox virus, RNA: ribonucleic acid, DNA: deoxyribonucleic acid, ACE2: angiotensin converting enzyme 2 receptors, MIS-C: multisystem inflammatory syndrome in children